Kawanabe, Yoshifumi, Nobuo Hashimoto, and Tomoh Masaki. Characterization of Ca 2ϩ channels involved in ET-1-induced transactivation of EGF receptors. Am J Physiol Heart Circ Physiol 283: H2671-H2675, 2002; 10.1152/ajpheart.00350.2002.-The purpose of this study was to demonstrate the involvement of Ca 2ϩ influx through voltage-independent Ca 2ϩ channels (VICCs) in endothelin-1 (ET-1)-induced transactivation of epidermal growth factor receptor protein tyrosine kinase (EGFR PTK) using the Ca 2ϩ channel blockers LOE-908 and SK&F-96365 in rabbit internal carotid artery vascular smooth muscle cells. ET-1-induced EGFR PTK transactivation was completely inhibited by AG-1478, which is a specific inhibitor of EGFR PTK. In the absence of extracellular Ca 2ϩ , the magnitude of EGFR PTK transactivation was near the basal level. Based on sensitivity to nifedipine, which is a specific blocker of voltage-operated Ca 2ϩ channels (VOCCs), VOCCs have minor roles in EGFR PTK transactivation. In contrast, Ca 2ϩ influx through VICCs plays an important role in EGFR PTK transactivation. Moreover, based on the sensitivity of VICCs to SK&F-96365 and LOE-908, VICCs were shown to consist of two types of Ca 2ϩ -permeable nonselective cation channels (NSCCs), which are designated NSCC-1 and NSCC-2, and a store-operated Ca 2ϩ channel. In summary, Ca 2ϩ influx through VICCs plays an essential role in ET-1-induced EGFR PTK transactivation in rabbit internal carotid artery vascular smooth muscle cells.
ENDOTHELIN (ET)-1 exhibits mitogenic activity in vascular smooth muscle cells (VSMCs; Refs. 1, 6, 7), which indicates a possible role for ET-1 in the pathogenesis of clinical conditions such as hyperlipoproteinemia or atherosclerosis (5, 8) . However, the molecular mechanisms of the ET-1-induced mitogenic response in VSMCs are still unclear. Recently, a novel aspect of the role of tyrosine kinase signaling in ET-1 action has been revealed by the finding in rat-1 fibroblasts that the ET type A (ET A ) receptor-mediated mitogenic response as well as other G protein-coupled receptormediated responses are accompanied by transactivation of the epidermal growth factor receptor (EGFR) protein tyrosine kinase (PTK). Through the formation of Shc/Grb2/Sos complexes, this event leads to activation of the ras/mitogen-activated protein kinase pathway and transcription of early-response genes (2, 10, 12) . Moreover, it was shown that vascular growth by ET-1 fully depends on this EGFR transactivation in VSMCs (6) .
We have recently shown (7) that ET-1 activates three types of voltage-independent Ca 2ϩ channels (VICCs) as well as voltage-operated Ca 2ϩ channels (VOCCs) in rabbit internal carotid artery VSMCs. The VICCs include two types of Ca 2ϩ -permeable nonselective cation channels (NSCC), which are designated NSCC-1 and NSCC-2, and a store-operated Ca 2ϩ channel (SOCC). Importantly, we have also shown that these channels can be distinguished by sensitivity to blockers of the receptor-operated Ca 2ϩ channel such as SK&F-96365 and LOE-908 (4, 9); NSCC-1 is sensitive to LOE-908 and resistant to SK&F-96365, NSCC-2 is sensitive to both LOE-908 and SK&F-96365, and SOCCs are resistant to LOE-908 and sensitive to SK&F-96365 (7). Moreover, Ca 2ϩ influx through NSCC-1, NSCC-2, and SOCCs plays an essential role for ET-1-induced mitogenesis in internal carotid artery VSMCs (7). Previous reports (3, 6, 10, 13) have demonstrated that extracellular Ca 2ϩ influx is important in EGFR PTK transactivation by angiotensin II, bradykinin, and ET-1. Extracellular Ca 2ϩ influx through VOCCs is involved in EGFR PTK transactivation in PC12 cells (10, 13) . However, it is totally unknown whether extracellular Ca 2ϩ influx through VICCs is involved in EGFR PTK phosphorylation. In the present study, we attempted to elucidate which Ca 2ϩ channels are involved in ET-1-induced EGFR PTK phosphorylation using SK&F-96365 and LOE-908 in internal carotid artery VSMCs.
MATERIALS AND METHODS
Cell culture. Rabbit internal carotid artery VSMCs were prepared as described previously (7) . Briefly, male Japan White rabbits (body wt, 2-3 kg) were anesthetized by injection of thiopental sodium (20 mg/kg iv) and killed by exsanguination. The internal carotid artery was removed, cleaned of surrounding tissue, dissected into small (2 ϫ 5 mm) strips, and kept in Ca 2ϩ -free Krebs-HEPES solution that contained (in mM) 140 NaCl, 3 KCl, 1 MgCl2, 11 glucose, and 10 HEPES (pH 7.3, adjusted with NaOH). The strips were incubated overnight (12-24 h) at 4°C in Ca 2ϩ -free Krebs-HEPES solution that contained papain (0.2-0.3 mg/ml) and 0.5 mM dithiothreitol. Thereafter, the strips were resuspended and incubated in Ca 2ϩ -free Krebs-HEPES solution that contained collagenase (0.25-0.5 mg/ml) at 35°C for 10 min. The digested strips were cut into pieces with fine scissors and triturated with a blunt-tipped pipette until a sufficient number of single cells were released. Cells were routinely maintained in Dulbecco's modified Eagle's medium that contained 10% fetal bovine serum in a humidified atmosphere of 5% CO 2-95% air.
Measurement of EGFR PTK transactivation. Transactivation of EGFR PTK was measured using a universal tyrosine kinase assay kit (Takara; Tokyo, Japan). Extraction buffer and kinase-reacting solution were included with this kit. Cells seeded at 5 ϫ 10 6 cells/well in six-well plates were starved for 24 h and then stimulated with various concentrations of ET-1 for the indicated times. The reaction was terminated by washing the cells three times with phosphatebuffered saline. After the addition of 1 ml of extraction buffer, the cells were scraped off with a scraper and centrifuged at 14,500 rpm for 10 min at 4°C. The supernatant was incubated with mouse monoclonal anti-EGFR antibody (Takara) for 1 h at room temperature and subsequently incubated with protein A agarose for an additional 20 min. The mixture was centrifuged at 10,000 g for 1 min at 4°C, and the pellets were washed three times with phosphate-buffered saline. The washed pellets were resuspended in 150 l of kinase-reaction buffer. EGFR PTK transactivation was determined according to the manufacturer's instructions. The absorbance of the lysate at 450 nm was measured using an EL340 microtiter plate reader (Bio-Tek Instruments; Winooski, VT).
Immunoblotting. The samples that were resuspended with kinase-reaction buffer were analyzed on 12% SDS-PAGE and transferred electrophoretically to polyvinylidene difluoride membranes (15 V for 90 min). Membranes were blocked with 5% bovine serum albumin for 1 h and were allowed to react with anti-phosphotyrosine monoclonal antibody (Santa Cruz Biotechnology) or mouse monoclonal anti-EGFR antibody for 1 h. The blots were washed and incubated with horseradish peroxidase-conjugated secondary antibodies for 1 h. After the washing phase, immunoreactive proteins were detected via the enhanced chemiluminscence system.
Drugs. LOE-908 was kindly provided by Boehringer Ingelheim (Ingelheim, Germany). Other chemicals were obtained from the following sources: ET-1 from the Peptide Institute (Osaka, Japan), SK&F-96365 from BioMol (Plymouth Meeting, PA), and AG-1478 from Funakoshi (Tokyo, Japan). All other chemicals were of reagent grade and were obtained commercially.
Statistical analysis. All results are expressed as means Ϯ SE. Data were subjected to a two-way ANOVA, and when a significant F-value was encountered, the Newman-Keuls multiple-range test was used to test for significant differences between treatment groups. A probability level of P Ͻ 0.05 was considered statistically significant.
RESULTS

Effects of ET-1 on EGFR PTK transactivation in
VSMCs. The tyrosine-phosphorylated protein (ϳ180 kDa) was assumed to be EGFR because it was recognized by the anti-EGFR antibody (Fig. 1A) . ET-1-induced EGFR PTK transactivation was inhibited remarkably by 5 M BQ-123, which is a specific blocker of ET A receptors, whereas it was not inhibited significantly by 5 M BQ-788, which is a specific blocker of ET B receptors (Fig. 1A) . EGFR PTK transactivation by 10 nM ET-1 increased with time and reached a peak value after ϳ2 min (Fig. 1B) . Thus the stimulation time was set at 2 min. ET-1 activated EGFR PTK in a concentration-dependent manner; EC 50 values were ϳ1 nM (Fig. 1C) . The stimulation reached a maximum at concentrations Ն10 nM (Fig. 1C) .
AG-1478, which is a specific inhibitor of EGFR PTK, inhibited ET-1-induced EGFR PTK transactivation ( Fig. 2A) . The inhibitory effects of AG-1478 on ET-1 induced EGFR PTK transactivation in a concentrationdependent manner. IC 50 values were ϳ10 nM, and Յ1 M AG-1478 provided complete inhibition (Fig. 2B) .
Effects of extracellular Ca 2ϩ and nifedipine on ET-1-induced EGFR PTK transactivation. In the absence of extracellular Ca 2ϩ , the magnitude of ET-1-induced EGFR PTK transactivation was near the basal level (Fig. 3) . Therefore, extracellular Ca 2ϩ influx plays an important role in the ET-1-induced EGFR PTK transactivation.
Next, we examined the effects of extracellular Ca transactivation using nifedipine, which is a specific blocker of L-type VOCCs. At a concentration of 1 M, nifedipine inhibited the ET-1-induced extracellular Ca 2ϩ influx through VOCCs in VSMCs (7); in contrast, nifedipine inhibited ET-1-induced EGFR PTK transactivation by a maximum of only ϳ10% (Fig. 3B) .
Effects of SK&F-96365 and LOE-908 on ET-1-induced EGFR PTK transactivation. Using SK&F-96365
and LOE-908, we attempted to determine the effects of extracellular Ca 2ϩ influx through VICCs on the ET-1-induced EGFR PTK transactivation. In these experiments, nifedipine was added to the incubation media at a final concentration of 1 M to analyze the role of Ca 2ϩ channels other than VOCCs. SK&F-96365 inhibited ET-1-induced EGFR PTK transactivation in a concentration-dependent manner, and the IC 50 value was ϳ3 M (Fig. 4A) . Maximal inhibition was observed at concentrations Ն10 M (Fig. 4A) . The extent of maximal inhibition was ϳ80% of the nifedipine-resistant part of EGFR PTK transactivation (Fig. 4B) . Similarly, the IC 50 values of LOE-908 for inhibition of ET-1-induced EGFR PTK transactivation were ϳ3 M, and maximal inhibition was observed at concentrations Ն10 M (Fig. 4A) . The extent of maximal inhibition was ϳ60% of EGFR PTK transactivation (Fig. 4B) . Notably, the combined treatment with the maximally effective concentrations (10 M) of SK&F-96365 and LOE-908 completely inhibited the nifedipine-resistant part of EGFR PTK transactivation (Fig. 4B) .
In contrast, EGF-induced EGFR PTK activation (Fig. 5 ) and phorbol 12-myristate 13-acetate-induced EGFR PTK transactivation (data not shown) were unaffected by SK&F-96365 or LOE-908. 
DISCUSSION
As described in previously (6), ET-1 induces EGFR PTK phosphorylation in rabbit internal carotid artery VSMCs (see Fig. 1A ). Based on its sensitivity to BQ-123 and BQ-788, ET A receptors play essential roles in the ET-1-induced EGFR PTK phosphorylation (Fig.  1A) . In the present study, we used a universal tyrosine kinase assay kit and mouse monoclonal anti-EGFR antibody for measurement of EGFR PTK phosphorylation. The ET-1-induced PTK phosphorylation obtained using this method was completely inhibited by AG-1478, which is a specific EGFR PTK inhibitor (Ref. 6; see Fig. 2B ). Moreover, the magnitude of ET-1-induced EGFR PTK phosphorylation in internal carotid artery VSMCs treated with AG-1478 was near basal level in the immunoblotting analysis ( Fig. 2A) . Therefore, we concluded that this method was suitable for measurement of EGFR PTK phosphorylation.
Previous reports (3, 6) demonstrated that extracellular Ca 2ϩ influx plays important roles in the EGFR PTK transactivation. We tried to characterize the Ca 2ϩ channels involved in the ET-1-induced EGFR PTK transactivation in internal carotid artery VSMCs. The magnitudes of ET-1-induced EGFR PTK transactivation in the absence of extracellular Ca 2ϩ were near the basal level (see Fig. 3 ). These results indicate that extracellular Ca 2ϩ influx is also important in ET-1-induced EGFR PTK transactivation in internal carotid artery VSMCs. Our recent study indicated that NSCC-1, NSCC-2, and SOCCs play major parts in ET-1-induced extracellular Ca 2ϩ influx in internal carotid artery VSMCs (7). Moreover, extracellular Ca 2ϩ influx through these Ca 2ϩ channels is essential in ET-1-induced mitogenesis (7). Thus we examined the involvement of NSCC-1, NSCC-2, and SOCCs in ET-1-induced EGFR PTK transactivation using SK&F-96365 and LOE-908. According to the nifedipine sensitivity of ET-1-induced EGFR PTK transactivation, involvement of VOCCs in this response was estimated to be minor at around ϳ10% (see Fig. 3B ). We demonstrated in a recent report (7) that nifedipine suppressed the 10 nM ET-1-induced sustained increase in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) by a maximum of 10%. Therefore, Ca 2ϩ channels that play important roles in ET-1-induced EGFR PTK transactivation in internal carotid artery VSMCs are different from those in PC12 cells (10, 13) . Ca 2ϩ channels other than VOCCs may be important in ET-1-induced EGFR PTK transactivation in addition to extracellular Ca 2ϩ influx in rabbit internal carotid artery VSMCs.
For several reasons, the inhibitory actions of SK&F-96365 and LOE-908 on the ET-1-induced EGFR PTK transactivation are considered to be mediated by blockade of Ca 2ϩ entry through VICCs. First, in our recent work using patch-clamp and [Ca 2ϩ ] i monitoring, ET-1 was found to activate three types of VICCs in VSMCs: NSCC-1, NSCC-2, and SOCCs. In addition, LOE-908 was found to be a blocker of both NSCC-1 and NSCC-2, whereas SK&F-96365 was found to be a blocker of NSCC-2 and SOCCs (7). Second, the IC 50 values of these blockers for the ET-1-induced EGFR PTK transactivation (see Fig. 4A ) correlated well with those for the ET-1-induced extracellular Ca 2ϩ influx (7) . Third, these blockers failed to inhibit EGF-induced EGFR PTK activation (Fig. 5) . Fourth, these blockers failed to inhibit phorbol 12-myristate 13-acetate-induced EGFR PTK transactivation (data not shown) that was independent of extracellular Ca 2ϩ influx (11) . Fifth, neither SK&F-96365 nor LOE-908 is considered to exert cytotoxic effects on the quiescent cells (7) . Moreover, because SK&F-96365 and LOE-908 failed to inhibit the ET-1-induced transient increase in [Ca 2ϩ ] i due to the release of intracellular Ca 2ϩ stores (7), the release of sarcoplasmic reticulum Ca 2ϩ was not sufficient to stimulate EGFR PTK transactivation. Three types of VICCs seem to be involved in the ET-1-induced EGFR PTK transactivation in terms of its sensitivity to SK&F-96365 and LOE-908 (see Figs. 4 and 6) . One type of Ca 2ϩ channel is sensitive to LOE-908 and resistant to SK&F-96365, another type is sensitive to both LOE-908 and SK&F-96365, and the third type is resistant to LOE-908 and sensitive to SK&F-96365. Based on pharmacological criteria, these channels are considered to be NSCC-1, NSCC-2, and SOCCs, respectively. Moreover, the percent contributions of NSCC-1, NSCC-2, and SOCCs to the ET-1-induced EGFR PTK transactivation are calculated to be ϳ20, 40, and 40%, respectively, of the nifedipine-resistant part of EGFR PTK transactivation caused by a 10 nM concentration of ET-1 (Fig. 6) . The magnitudes of the ET-1-induced EGFR PTK transactivations that were inhibited by the combined treatment with nifedipine, SK&F-96365, and LOE-908 were similar to those in the absence of extracellular Ca 2ϩ (see Figs. 3B and 4B ). Therefore, extracellular Ca 2ϩ influx through NSCC-1, NSCC-2, and SOCCs plays an important role in ET-1-induced EGFR PTK transactivation in rabbit internal carotid artery VSMCs. In conclusion, extracellular Ca 2ϩ influx through NSCC-1, NSCC-2, and SOCCs plays an essential role for ET-1-induced EGFR PTK transactivation in rabbit internal carotid artery VSMCs.
